Recognizing the Financial Burden of Cancer Patients in Clinical Trials
Open Access
- 18 May 2015
- journal article
- editorial
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 20 (6), 572-575
- https://doi.org/10.1634/theoncologist.2015-0068
Abstract
Clinical trials often represent an increasingly important option for patients with cancer, thus oncologists participating in clinical research need to consider and address the financial burden associated with trial participation. Future research efforts should focus on developing formal screening tools to identify and monitor for financial burden among clinical trial participants.Keywords
This publication has 29 references indexed in Scilit:
- Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standardsQuality of Life Research, 2012
- National Estimates of Out-of-Pocket Health Care Expenditure Burdens Among Nonelderly Adults With Cancer: 2001 to 2008Journal of Clinical Oncology, 2011
- Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trialBMC Cancer, 2011
- A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group ProgramJNCI Journal of the National Cancer Institute, 2010
- Analysis of Maryland Cancer Patient Participation in National Cancer Institute–Supported Cancer Treatment Clinical TrialsJournal of Clinical Oncology, 2008
- Overcoming barriers to cancer clinical trial accrualCancer, 2007
- Enrollment of Elderly Patients in Clinical Trials for Cancer Drug Registration: A 7-Year Experience by the US Food and Drug AdministrationJournal of Clinical Oncology, 2004
- The Costs of Conducting Clinical ResearchJournal of Clinical Oncology, 2003
- The impact of serious illness on patients' families. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of TreatmentJAMA, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993